RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Resolute Advisors LLC's Holding History (CIK: 0001800217)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 14,670 Value ($000) $72 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 14,670 Value ($000) $74 Avg Close $4.91 Range $3.79 - $6.11
Q4 2024
Shares 14,670 Value ($000) $99 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 14,670 Value ($000) $97 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 14,670 Value ($000) $110 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 14,670 Value ($000) $146 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 14,670 Value ($000) $145 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 14,670 Value ($000) $112 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 11,002 Value ($000) $82 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 11,002 Value ($000) $73 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 11,002 Value ($000) $85 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 11,002 Value ($000) $117 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 9,168 Value ($000) $75 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 9,168 Value ($000) $66 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 9,168 Value ($000) $157 Avg Close $18.82 Range $15.25 - $23.86